Century Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.45

+0.04 (+1.66%)

As of Jun 30, 10:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +1,016.3% upside

Low Target $22.03

Average Target $27.35

High Target $42.34

Current Price $2.45

Current
$2.45

Target
$27.35

$22.03 $27.35 avg $42.34

Scenario Analysis

Bear Case

$22.03

799.2%

Low target

Base Case

$27.35

+1,016.3%

Avg target

Bull Case

$42.34

+1,628.2%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$3.04

-19.4% from high

52-Week Low

$0.44

+463.2% from low

Target vs 52W High

$27.35

+799.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%